(Q50132026)

25 February 2018

title

Insurance status is related to diffuse large B-cell lymphoma survival (English)

1 reference

25 February 2018

diffuse large B-cell lymphoma

1 reference

1 reference

5

Loretta J Nastoupil

1 reference

25 February 2018

author name string

Xuesong Han

1

1 reference

25 February 2018

Ahmedin Jemal

2

1 reference

25 February 2018

Christopher R Flowers

3

1 reference

25 February 2018

Helmneh Sineshaw

4

1 reference

25 February 2018

Elizabeth Ward

6

1 reference

25 February 2018

language of work or name

English

0 references

publication date

28 January 2014

1 reference

25 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

25 February 2018

volume

120

1 reference

25 February 2018

issue

8

1 reference

25 February 2018

page(s)

1220-1227

1 reference

25 February 2018

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Association of insurance with cancer care utilization and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Factors associated with immunotherapy use among newly diagnosed cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Survival disparities by Medicaid status: an analysis of 8 cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Practical considerations on the use of the Charlson comorbidity index with administrative data bases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Cross-national comparative performance of three versions of the ICD-10 Charlson index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Sorting out the connections between the built environment and health: a conceptual framework for navigating pathways and planning healthy cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Examining racial differences in diffuse large B-cell lymphoma presentation and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

Delays in cancer diagnosis in underinsured young adults and older adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28549

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.28549

1 reference

25 February 2018

1 reference

25 February 2018